Neurology
Mithridion, Inc. Announces New Funding and Outlines Strategy for Central Nervous System Drug Development
January 11, 2011 2:33 am | by Bio-Medicine.Org | News | CommentsMADISON, Wis. and TOLEDO, Ohio, Jan. 11, 2011 /- Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding....
MedAvante Names Leading Expert to Head Neurocognition Therapeutic Area
January 10, 2011 7:35 am | by Bio-Medicine.Org | News | CommentsHAMILTON, N.J., Jan. 10, 2011 /- MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system (CNS) disorders, announced the appointment of Christopher Randolph, PhD, ABPP-CN, to the new position of Vice President, Neurocognition. Dr....
Shionogi Inc. Announces Commercial Availability of KAPVAYâ„¢ (clonidine hydrochloride) Extended-Release Tablets for the Treatment of ADHD
January 10, 2011 4:36 am | by Bio-Medicine.Org | News | CommentsFLORHAM PARK, N.J., Jan. 10, 2011 /- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced a true milestone as it marks the first commercial availability for the non-central nervous system stimulant medication KAPVAY™, an extended-release oral...
Boston Scientific buys Intelect Medical for $60M
January 6, 2011 3:35 am | by Mass High Tech: The Journal of New England Technology | News | CommentsBoston Scientific Corp. has acquired Intelect Medical Inc., a Boston-based company that recently moved here from Ohio, and is developing technologies for deep brain stimulation, for $60 million in cash.
Boston Scientific Acquires Intelect Medical
January 5, 2011 11:34 am | by Boston Scientific | News | CommentsInnovative technology designed to advance deep brain stimulation therapy
Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference in San Francisco on January 12
January 5, 2011 2:35 am | by Bio-Medicine.Org | News | CommentsPALO ALTO, Calif., Jan. 5, 2011 /- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today that the company will make a presentation at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 12, 2011 at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time. Bruce...
MAP Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
January 4, 2011 1:36 pm | by Bio-Medicine.Org | News | CommentsMOUNTAIN VIEW, Calif., Jan. 4, 2011 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that the company will present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011 at 8:00 a.m. PT in San Francisco. A live webcast of the presentation will be...
Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy
December 29, 2010 4:36 am | by Bio-Medicine.Org | News | CommentsSEATTLE, Dec. 29, 2010 /- Omeros Corporation (Nasdaq: OMER ), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced results from the Phase 1/2 clinical trial of...
Football League Funds Medical School Inquiry
December 27, 2010 4:36 am | by San Diego Business Journal | News | CommentsNFL Charities, the philanthropic arm of the National Football League owners, has awarded more than $1.6 million in grants to support sports-related medical research organizations, including nearly $100,000 that will go to a team of researchers at UC San Diego School of Medicine.
Cannabis Science Forms Military Advisory Board That Will Be Comprised of Distinguished Military Leaders, Military Health Care Providers, Researchers and Educators Headed Up by...
December 23, 2010 7:31 am | by Bio-Medicine.Org | News | CommentsCOLORADO SPRINGS, Colo., Dec. 23, 2010 /- Cannabis Science, Inc. (OTC Bulletin Board: CBIS ), a pioneering U.S. biotech company developing pharmaceutical cannabis products, announced today that it has formed a Military Advisory Board, that will be comprised of distinguished military...
Jazz Pharmaceuticals Announces New Patent Issued for Sodium Oxybate(2)
December 21, 2010 5:34 pm | by Bio-Medicine.Org | News | CommentsPALO ALTO, Calif., Dec. 21, 2010 /- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today announced that the United States Patent and Trademark Office (USPTO) has issued a patent related to Xyrem® (sodium oxybate) oral solution titled "Microbiologically Sound and Stable Solutions of...
Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA
December 21, 2010 2:37 pm | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Dec. 21, 2010 /- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today that Jack Lief, Arena's President and Chief Executive Officer, will host a conference call and webcast tomorrow, Wednesday, December 22, 2010, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) to...
U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels
December 16, 2010 4:36 pm | by Bio-Medicine.Org | News | CommentsWAYNE, N.J., Dec. 16, 2010 /- Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate...
Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly
December 16, 2010 2:31 am | by Bio-Medicine.Org | News | CommentsANN ARBOR, Mich., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that it has acquired access to clinical data supporting a zinc-based therapy for the...
Big possibilities in brain-computer interface
December 15, 2010 4:34 pm | by Arizona State University | News | CommentsAn ASU researcher talks about progress in brain-computer interface technology being developed to help people incapacitated by injury or neurological disorders.read more
China Botanic Achieves Three Million RMB Sales of New Product
December 14, 2010 6:39 am | by Bio-Medicine.Org | News | CommentsHARBIN, China, Dec. 14, 2010 /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical Inc. (AMEX: CBP ) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced...
Nolen named InVivo lead director
December 13, 2010 10:35 am | by Mass High Tech: The Journal of New England Technology | News | CommentsInVivo Therapeutics Holding Corp. has appointed George Nolen, former Siemens Corp. president and CEO, as lead director of the Cambridge developer of therapeutics for spinal cord injuries.
Curemark Appoints Jennifer Katritos, CPA as Vice President of Finance
December 13, 2010 10:35 am | by Bio-Medicine.Org | News | CommentsRYE, N.Y., Dec. 13, 2010 /- Curemark, LLC , a drug research and development company focused on the treatment of neurological diseases, has appointed Jennifer Katritos, CPA, as vice president of finance, the company announced. She joined Curemark in July, 2009 as director of finance....
Denosumab Delayed Time to First Skeletal-related Side Effect
December 10, 2010 8:32 am | by AACR | News | CommentsSAN ANTONIO - For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared to those on zoledronic acid, according to results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
A Magnetic Shortcut to Clinical Trials
December 9, 2010 8:34 pm | by Massachusetts Institute of Technology | News | CommentsFinding effective drug dosages using MRI could accelerate drug development.
Study Eyes Hypothermia's Potential to Help Stroke Patients
December 8, 2010 12:33 pm | by San Diego Business Journal | News | CommentsResearchers at the UC San Diego School of Medicine are part of the largest clinical trial of hypothermic brain cooling for stroke to date.
The New MindView 4 Mind Mapping Software Takes Online Collaboration to the Next Level
December 8, 2010 12:35 am | by RealWire | News | CommentsWith impressive new features that make online collaboration faster and easier than ever, MindView 4 is the most powerful Mind Mapping tool to date. Tampa, FL - December 8, 2010. After 18 months of gathering feedback from users, MatchWare has just released MindView 4, the next generation...
Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study
December 7, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsHAMILTON, N.J., Dec. 7, 2010 /- MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study. Cipher recently...
New Trial Studies Link Between Stroke and Atrial Fibrillation
December 7, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsCHICAGO, Dec. 7, 2010 /PRNewswire-USNewswire/ -- One evening last March, Larry Ambrose left his bed in the middle of the night to check the time. Much to the 71-year-old's surprise, he was only able to see three out of the four glowing numbers on the digital clock in his kitchen. Ambrose...
Passages Malibu Drug and Alcohol Treatment Center Announces Launch of Cutting-Edge 'Brain Paint' Neurofeedback Therapy Scientifically Proven to Reduce Addiction Relapse Rate I...
December 7, 2010 4:35 am | by Bio-Medicine.Org | News | CommentsMALIBU, Calif., Dec. 7, 2010 /- The world-renowned Passages Malibu, the state-of-the-art one-on-one holistic drug and alcohol treatment center, today announced the launch of the "Brain Paint" Neurofeedback, scientifically proven to reduce relapse, as the latest cutting-edge therapy...
